Key Considerations For Selecting a Genomic Decision Support Platform For Implementing Pharmacogenomics

被引：5

作者：

Cook, Kelsey J. ^{[1
,2
]}

Duong, Benjamin Q. ^{[3
]}

Seligson, Nathan D. ^{[1
,2
]}

Arn, Pamela ^{[2
]}

Funanage, Vicky L. ^{[3
]}

Gripp, Karen W. ^{[3
,4
]}

Kirwin, Susan M. ^{[3
]}

Lawless, Stephen T. ^{[3
,4
]}

Lee, Mary M. ^{[3
,4
]}

Robbins, Katherine M. ^{[3
]}

West, David ^{[3
]}

Blake, Kathryn V. ^{[2
]}

机构：

[1] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Jacksonville, FL USA

[2] Nemours Childrens Hlth, Precis Med Program, Jacksonville, FL 32207 USA

[3] Nemours Childrens Hlth, Precis Med Program, Wilmington, DE USA

[4] Sidney Kimmel Med Coll, Philadelphia, PA USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 110卷 / 03期

关键词：

D O I：

10.1002/cpt.2328

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Clinical implementation of pharmacogenomics (PGx) is dependent on integration of PGx results into the electronic health record (EHR) and clinical decision support (CDS) systems. Historically, PGx programs have utilized homegrown EHR integration and CDS. Many institutions cannot develop their own PGx CDS and little is reported about the selection and use of external genomic support vendors for PGx. We share our experience choosing a genomic support vendor for implementing PGx at a pediatric health system.

引用

页码：555 / 558

页数：4

共 50 条

[41] Selecting advanced analytics in manufacturing: a decision support model
Lorenz, Rafael
Kraus, Mathias
Wolf, Hergen
Feuerriegel, Stefan
Netland, Torbjorn H.
PRODUCTION PLANNING & CONTROL, 2024, 35 (07) : 711 - 724
[42] Decision support tool for selecting fabrication parameters in stereolithography
J. Giannatsis
V. Dedoussis
The International Journal of Advanced Manufacturing Technology, 2007, 33 : 706 - 718
[43] Sequencing depth and coverage: key considerations in genomic analyses
David Sims
Ian Sudbery
Nicholas E. Ilott
Andreas Heger
Chris P. Ponting
Nature Reviews Genetics, 2014, 15 : 121 - 132
[44] Sequencing depth and coverage: key considerations in genomic analyses
Sims, David
Sudbery, Ian
Ilott, Nicholas E.
Heger, Andreas
Ponting, Chris P.
NATURE REVIEWS GENETICS, 2014, 15 (02) : 121 - 132
[45] A Pharmacogenomics Clinical Decision Support Service Based on FHIR and CDS Hooks
Dolin, R. H.
Boxwala, A.
Shalaby, J.
METHODS OF INFORMATION IN MEDICINE, 2018, 57 : E115 - E123
[46] Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
Zhou, Yitian
Lauschke, Volker M.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (03) : 213 - 223
[47] Evaluation of the use of clinical decision support and online resources for pharmacogenomics education
Vitek, Carolyn R. Rohrer
Nicholson, Wayne T.
Schultz, Cloann
Caraballo, Pedro J.
PHARMACOGENOMICS, 2015, 16 (14) : 1595 - 1603
[48] Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics results
Massmann, Amanda
Van Heukelom, Joel
Larson, Chad
Starks, Rachel D.
PHARMACOGENOMICS, 2022, : 987 - 993
[49] Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts
Nguyen, Jenny Q.
Crews, Kristine R.
Moore, Ben T.
Kornegay, Nancy M.
Baker, Donald K.
Hasan, Murad
Campbell, Patrick K.
Dean, Shannon M.
Relling, Mary, V
Hoffman, James M.
Haidar, Cyrine E.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2022, 30 (01) : 132 - 138
[50] Designing and implementing reflective practice programs Key principles and considerations
Parrish, Dominique R.
Crookes, Kay
NURSE EDUCATION IN PRACTICE, 2014, 14 (03) : 265 - 270

← 1 2 3 4 5 →